Trial Details
COMPLETEDBasic Information
| Clinical ID | c4681 |
|---|---|
| Identifier | NCT00142987 |
| Trial Title | Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | IBS-C and IBS With Mixed Bowel Habits |
| Interventions | DRUG: Tegaserod |
Participant Information
| Sponsor | Novartis |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2004-04 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 2005-06 |